With the development of NOD-SCID mice with functionally defective lymphocytes and NK cells several groups successfully showed engraftment of mononuclear and CD34+ cells from PB of CML patients using lower cell numbers than those reported for SCID mouse models of CML [47–49]. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.